Status:
COMPLETED
TB PCR in BAL and EBUS-TBNA
Lead Sponsor:
Imperial College Healthcare NHS Trust
Collaborating Sponsors:
Chelsea and Westminster NHS Foundation Trust
The Hillingdon Hospitals NHS Foundation Trust
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Brief Summary
This prospective observational multi-centre UK study will evaluate Xpert MTB/RIF Ultra for the detection of Mycobacterium tuberculosis (MTB) in bronchoalveolar lavage (BAL) samples for pulmonary TB an...
Detailed Description
This is a prospective multi-centre study across the UK including London, Birmingham, Leicester and Manchester which account for the highest proportion of TB cases in the UK. These are centres routinel...
Eligibility Criteria
Inclusion
- Any consenting adult ≥18 years of age suspected of having pulmonary TB or mediastinal TB who is undergoing a routine clinical bronchoscopy or EBUS-TBNA
Exclusion
- Any patient who has had a BAL or EBUS-TBNA but has not had Xpert Ultra testing as part of routine diagnostics for possible TB
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
394 Patients enrolled
Trial Details
Trial ID
NCT04909385
Start Date
January 15 2021
End Date
February 29 2024
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom